CN Patent
CN102525915B — 一种持续释放的注射制剂及其制备方法和用途
Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2016-09-28 · 10y expired
What this patent protects
本发明涉及一种持续释放的注射制剂及其制备方法和用途。具体而言,本发明涉及一种持续释放注射制剂,包括精神类药物和非水性载体,该制剂可以在至少1周内持续释放。所述持续释放注射制剂缓释效果更好,更长效,更稳定,剂型简单,无须冻干,制备工艺更简易,成本更低廉,而且使用更方便。
USPTO Abstract
本发明涉及一种持续释放的注射制剂及其制备方法和用途。具体而言,本发明涉及一种持续释放注射制剂,包括精神类药物和非水性载体,该制剂可以在至少1周内持续释放。所述持续释放注射制剂缓释效果更好,更长效,更稳定,剂型简单,无须冻干,制备工艺更简易,成本更低廉,而且使用更方便。
Drugs covered by this patent
- Aristada (ARIPIPRAZOLE LAUROXIL) · Alkermes Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.